Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
CNY 8.29
(-0.72%)
CNY 8.29
(-0.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 484.13 Million CNY | -4.32% |
| 2022 | 340.55 Million CNY | 27.15% |
| 2021 | 267.84 Million CNY | 13.46% |
| 2020 | 236.06 Million CNY | 10.81% |
| 2019 | 213.03 Million CNY | 21.55% |
| 2018 | 175.26 Million CNY | 27.64% |
| 2017 | 137.31 Million CNY | -2.7% |
| 2016 | 141.12 Million CNY | 12.96% |
| 2015 | 124.94 Million CNY | 26.01% |
| 2014 | 99.15 Million CNY | 17.29% |
| 2013 | 84.54 Million CNY | 7.47% |
| 2012 | 78.66 Million CNY | 12.58% |
| 2011 | 69.87 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 96.54 Million CNY | 1.47% |
| 2024 Q3 | 96.11 Million CNY | 17.02% |
| 2024 Q1 | 95.14 Million CNY | -8.92% |
| 2023 Q3 | 91.09 Million CNY | 3.45% |
| 2023 Q4 | 104.46 Million CNY | 14.68% |
| 2023 FY | 325.84 Million CNY | -4.32% |
| 2023 Q1 | 81.45 Million CNY | -9.67% |
| 2023 Q2 | 88.05 Million CNY | 8.09% |
| 2022 Q4 | 90.18 Million CNY | 0.16% |
| 2022 Q3 | 90.03 Million CNY | -4.28% |
| 2022 Q2 | 94.05 Million CNY | 41.91% |
| 2022 Q1 | 66.27 Million CNY | -20.77% |
| 2022 FY | 340.55 Million CNY | 27.15% |
| 2021 Q3 | 59.24 Million CNY | -18.1% |
| 2021 FY | 267.84 Million CNY | 13.46% |
| 2021 Q1 | 52.6 Million CNY | -20.37% |
| 2021 Q2 | 72.33 Million CNY | 37.52% |
| 2021 Q4 | 83.65 Million CNY | 41.2% |
| 2020 Q1 | 44.32 Million CNY | -26.38% |
| 2020 Q3 | 66.39 Million CNY | 11.98% |
| 2020 FY | 236.06 Million CNY | 10.81% |
| 2020 Q2 | 59.28 Million CNY | 33.74% |
| 2020 Q4 | 66.05 Million CNY | -0.5% |
| 2019 Q2 | 57.51 Million CNY | 25.79% |
| 2019 FY | 213.03 Million CNY | 21.55% |
| 2019 Q4 | 60.21 Million CNY | 21.43% |
| 2019 Q3 | 49.58 Million CNY | -13.78% |
| 2019 Q1 | 45.72 Million CNY | -21.47% |
| 2018 Q2 | 37.14 Million CNY | 12.13% |
| 2018 Q1 | 33.12 Million CNY | -2.96% |
| 2018 FY | 175.26 Million CNY | 27.64% |
| 2018 Q4 | 58.22 Million CNY | 24.46% |
| 2018 Q3 | 46.77 Million CNY | 25.94% |
| 2017 FY | 137.31 Million CNY | -2.7% |
| 2017 Q2 | 34.51 Million CNY | 14.4% |
| 2017 Q3 | 38.5 Million CNY | 11.56% |
| 2017 Q4 | 34.13 Million CNY | -11.33% |
| 2017 Q1 | 30.16 Million CNY | -27.1% |
| 2016 Q3 | 35.86 Million CNY | -3.68% |
| 2016 Q2 | 37.22 Million CNY | 39.67% |
| 2016 Q4 | 41.38 Million CNY | 15.4% |
| 2016 FY | 141.12 Million CNY | 12.96% |
| 2016 Q1 | 26.65 Million CNY | -35.49% |
| 2015 Q1 | 21.61 Million CNY | 1137.73% |
| 2015 FY | 124.94 Million CNY | 26.01% |
| 2015 Q4 | 41.31 Million CNY | 29.87% |
| 2015 Q3 | 31.81 Million CNY | 5.37% |
| 2015 Q2 | 30.19 Million CNY | 39.69% |
| 2014 Q4 | 1.74 Million CNY | 0.0% |
| 2014 FY | 99.15 Million CNY | 17.29% |
| 2013 FY | 84.54 Million CNY | 7.47% |
| 2012 FY | 78.66 Million CNY | 12.58% |
| 2011 FY | 69.87 Million CNY | 0.0% |